Neuromuscular meetings & conferences

Accelerating Translational Neurotechnology: Fourth Annual Aspen Brain Forum

September 18 - 20, 2013 Aspen Meadows Resort

Presented by The Aspen Brain Forum Foundation, Science Translational Medicine, and the New York Academy of Sciences

Neurotechnology encompasses electrical, chemical, and medical devices and products that can interact with or intervene in the activity of the central nervous system. These technologies include neuroprosthetics, neuroengineering, neuroimaging, optogenetics, neuromodulation, and neural stem cell therapies. Translating neurotechnologies from the laboratory into clinical and commercial products has been an arduous process. Yet many of these new tools show great potential to revolutionize the treatment of neurological diseases and disorders including depression, pain, headache, epilepsy, neuromuscular disease, Alzheimer's disease, Parkinson's disease, and traumatic brain injury.

Through a series of plenary sessions, panel discussions, and interactive breakout groups, this 2.5-day international conference shall explore innovative scientific, clinical, and organizational models for advancing the translation of neuroscience research into technology that can dramatically improve diagnosis and treatment of neurological and psychiatric disease. Participants will also examine the ethical and regulatory challenges in translating neuroscience research, and the potential economic impact of their clinical application.

This conference includes a breakout session. During registration, you will be asked to choose a work group based on your area/disease of interest. Please pick your first and second choices for this session. You may also write in an alternate topic. We will create additional groups if there is sufficient interest. Registrants will receive an email with work group details several weeks prior to the conference.

Choices include: Parkinson's Disease, Major Depression and other Mood Disorders, Chronic Pain, Alzheimer's Disease, or Traumatic Brain Injury.

Grand Challenges in Parkinson's Disease

The Role of Inflammation

September 18-19, 2013 Grand Rapids, Michigan

Seventh Annual Huntington Disease Clinical Research Symposium (HDCRS)

Saturday, November 9, 2013 from 8:00am - 12:30pm Charlotte, North Carolina

10th International Congress on Mental Dysfunction and Non-Motor Features of Parkinson's Disease & Related Disorders

December 4-7, 2014 Nice, France

Join the 10th International Mental Disorders & Other Non-Motor Features in Parkinson’s disease Congress after several successful years of providing the world’s leading specialists with unparalleled access to the latest discoveries and developments in the study of the etiology and therapy of non-motor features of Parkinson’s disease.

MDPD 2014 is a leading annual educational forum offering a unique opportunity to deliberate on brain diseases and how they contribute to cognitive decline, and to identify the specific psychological markers, biochemical and genetic factors of Parkinson’s dementia and of dementia with Lewy bodies. Join your colleagues and discover the latest developments in our understanding of non motor aspects of the basal ganglia, pathological abnormalities related to PD and the genetic mutations resulting in movement disorders.

MDPD Congresses enable you to network with leading neurologists, psychiatrists, psychologists and other multidisciplinary specialists from around the world and exchange information of take-home value. After a highly successful gathering in Asia, MDPD will be returning to its European roots. Join your colleagues in Nice for four days of sun, fun and unexpected treasures in the capital of the French Riviera. 

Kenes International
1-3, Rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1
Switzerland
Tel: +41 22 908 0488
Fax: +41 22 906 9140
Email: mdpd@kenes.com

13th International Child Neurology Congress

May 4-9 2014 Iguazu Falls, Brazil

The 13th International Child Neurology Congress will be held in the city of Foz do Iguaçu (Iguazú River Mouth), Brazil, from  4 to 9 May 2014. This is the second time that an ICNC is held in Latin America the first one being in Buenos Aires, Argentina,  in 1992. The congress will be held jointly with the 9th Brazilian Congress of Child Neurology.

27th Annual Parkinson Study Group Symposium on Etiology, Pathogenesis, and Treatment  of Parkinson’s Disease and Other Movement Disorders

October 1, 2013  Montreal, Canada

The Parkinson Study Group (PSG), in collaboration with the Huntington Study Group (HSG), Dystonia Study Group (DSG), Tourette Syndrome Study Group (TSSG), Cooperative Ataxia Group (CAG), and Tremor Research Group (TRG), will present the 27th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson’s Disease and Other Movement Disorders on Tuesday, October 1, 2013, at Fairmont The Queen Elizabeth Hotel, in Montreal, Canada.  The peer-reviewed program includes both platform and poster presentations.

13th International Congress on Neuromuscular Diseases

July 5-10, 2014 Nice, France

The International Congress on Neuromuscular Diseases is the regular meeting of the Research Group on Neuromuscular Diseases-World Federation of Neurology (RGNMD-WFN).  The first one was organized more than 40 years ago, in 1969, in Milan – Italy and the second one, in 1971, in Perth - Australia. It was then firmly established as the most important forum by the global neuromuscular community, hosted on a 4-year event basis by several medical and research expert groups all around the world: North America, Australia, Japan, Turkey and Europe. The Organizing Committee of the ICNMD XIII is proud to have been selected by the Executive Committee of the RGNMD-WFN to manage the 2014 version and wishes to express its thanks for this commitment.

The ICNMD congress is a unique opportunity to share scientific advances in peripheral neurology by those involved in the fields of improving care, understanding disease pathogenesis, and developing innovative treatments in muscle, neuromuscular junction, peripheral neuropathies and motor neuron diseases. This is an optimal meeting place for upgrading knowledge for young as well as established physicians and researchers, and for stimulating discussions and exchanges of views and ideas with colleagues in the focused areas.  The goal of the plenary session program is to attract speakers of the highest international calibre who will give engaging and thought-provoking presentations on a range of up to date topics and moves in advanced concepts. We are grateful to those who have accepted invitations to organize and  peak in the thematic workshop sessions which will be focused on the most up to date works in progress. A large place will be dedicated to the selected submitted abstracts on regular poster sessions but also with specific highlighting through poster flash sessions in which selected authors will have the chance of a 3-slides oral presentation or through highlight poster sessions summarizing the most important late breaking news brought by attendees. Moreover, attendees will have the opportunity to register for teaching courses with lessons from experts and for breakfast seminars conducted by brilliant young scientists or MDs on recent concepts.

Contact us

CONGRESS OFFICE

ICNMD 2014 - MCO Congrès
27, rue du Four à Chaux
13007 Marseille, France

Tel.: +33 (0)4 95 09 38 00 – Fax: +33 (0)4 95 09 38 01
E-mail: natalie.ruxton@mcocongres.com

World Parkinson Congress 2013

3rd World Parkinson Congress (WPC 2013) Montreal, Canada October 1 to 4, 2013

The World Parkinson Congresses provide an international forum for the latest scientific discoveries, medical practices and care initiatives related to Parkinson disease. By bringing physicians, scientists, nurses, rehab professionals, policy advocates, care partners, family members and people with Parkinson's disease together, we aim to create a worldwide dialogue that will help expedite the discovery of a cure and best treatment practices for this devastating disease.

Plans are underway for the third World Parkinson Congress from October 1 - 4, 2013 to be held at the Palais des congrès in Montreal, Canada. The WPC 2013 is on track to be as successful as the first two Congresses but we can only do it with your involvement. The WPC 2013 is more than just a meeting. We hope to leave a legacy behind. When planning each WPC, we work with the local community to raise awareness about and increase the quality of life of people living with Parkinson disease. Please join us and help make this vision a reality in Montreal in 2013.

XX World Federation of Neurology World Congress on Parkinson's Disease and Related Disorders

December 8-11, 2013 Geneva, Switzerland

Integration by Translation

The XX WFN World Congress on Parkinson's Disease and Related Disorders is an innovative educational forum for learning about the latest research and discoveries in etiology, pathogenesis, potential diagnostic markers and treatment modalities of Parkinson’s Disease and its related disorders.

Sponsored by the World Federation of Neurology’s Association of Parkinsonism and Related Disorders, this biennial event is internationally recognized for the scope of its program, which covers a wide range of topics and consists of the world’s preeminent experts. Being held in beautiful Geneva, this congress is sure to attract a large faculty of distinguished scientists, clinicians and allied health experts from Europe and around the world.

Kenes International
1-3 Rue de Chantepoulet,
PO Box 1726, CH-1211,
Geneva 1, Switzerland
Tel: + 41 22 908 0488
Fax: + 41 22 906 9140
E-mail: parkinson@kenes.com

WCN 2013 XXI World Congress of Neurology

September 21-26, 2013 Vienna, Austria

Join leading neurologists at WCN 2013, the world’s biggest neurology event. The XXI World Congress of Neurology will feature a rich scientific programme, including the latest developments in clinical practice and research, distinguished plenary speakers, teaching courses, workshops, and lectures, all on the increasingly global aspect of our work.

List of Proposed Topics

Epilepsy (Joint WFN & ILAE)
Movement Disorders
Stroke (Joint WSO & WFN)
Neuro-critical care
Dementia
MS & Demyelinating Diseases
Neuromuscular disorders
Headache
Pain
Neurorehabilitation
Neurooncology
CNS infection
Vertigo and balance disorders
Sleep
Leukoencephalopathies & Child neurology
Autoimmune encephalitis
Neurology, Health economics & outcomes
Metabolic and mitochondrial diseases
Neuroepidemiology
Environment, Climate Change
Autonomic nervous system
Neuroophthalmology
Brain & Behavior
Motor neuron disease
Channelopathies
Palliative care
Nutritional disorders & Neurotoxins
Stem cells in Neurology, hopes, uses and abuses
Neurological surgery for the neurologist
Psychiatry for the neurologist
Neuroethics
Interventional Neuroradiology
Advances in Neuroimaging
Advances in Neurophysiology
Therapeutic Neurotoxins
Biomarkers
World History of Neurology
You Tube neurology
Movies and neurology
Sports neurology
Training in neurology around the world
WHO Neurology Initiatives (Noncommunicable disease Initiative, MhGAP Program, ICD-11 revision of neurology codes)
Cases from around the world
Making the Case for Neurology

Contact Us
Please email us at wcn@kenes.com for more information or any queries.